Busulfan, cyclophosphamide and fractionated total body irradiation for autologous or syngeneic marrow transplantation for acute and chronic myelogenous leukemia: phase I dose escalation of busulfan based on targeted plasma levels - Demirer,T.; Buckner,C.D.; Appelbaum,F.R. (Bone Marrow Transplant, 1996)